RAYMOND JAMES TRUST N.A. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
RAYMOND JAMES TRUST N.A. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,441,934
+100383.2%
14,156
-0.5%
0.04%
+2.4%
Q2 2023$1,435
+3.4%
14,225
-5.7%
0.04%
-4.5%
Q1 2023$1,388
-6.7%
15,086
-8.0%
0.04%
-12.0%
Q4 2022$1,488
-99.9%
16,404
-1.1%
0.05%
+6.4%
Q3 2022$1,261,000
-13.2%
16,590
-3.4%
0.05%
-9.6%
Q2 2022$1,452,000
-17.6%
17,177
-14.5%
0.05%
-3.7%
Q1 2022$1,763,000
+5.0%
20,099
+4.7%
0.05%
+8.0%
Q4 2021$1,679,000
+3.3%
19,198
-3.4%
0.05%
-7.4%
Q3 2021$1,625,000
-13.9%
19,866
-4.0%
0.05%
-14.3%
Q2 2021$1,888,000
-26.3%
20,694
-31.0%
0.06%
-29.2%
Q1 2021$2,562,000
-28.6%
29,970
-21.1%
0.09%
-35.0%
Q4 2020$3,588,000
+8.2%
37,996
-0.4%
0.14%
-4.2%
Q3 2020$3,316,000
-6.8%
38,131
-6.4%
0.14%
-16.9%
Q2 2020$3,557,000
+18.8%
40,726
+12.1%
0.17%
-2.8%
Q1 2020$2,995,000
-17.8%
36,322
-5.7%
0.18%
+1.7%
Q4 2019$3,645,000
+9.3%
38,499
+0.3%
0.17%
+1.2%
Q3 2019$3,335,000
-32.4%
38,370
-29.0%
0.17%
-36.8%
Q2 2019$4,933,000
+4.1%
54,019
+9.6%
0.27%
-0.4%
Q1 2019$4,737,000
+16.2%
49,271
+3.8%
0.27%
+4.2%
Q4 2018$4,075,000
+0.1%
47,483
+0.4%
0.26%
+14.4%
Q3 2018$4,072,000
+61.7%
47,271
+41.8%
0.23%
+49.7%
Q2 2018$2,518,000
+1.9%
33,333
+9.1%
0.15%
-10.5%
Q1 2018$2,470,000
-4.2%
30,539
-0.5%
0.17%
-1.7%
Q4 2017$2,577,000
-5.6%
30,698
-3.4%
0.17%
-10.8%
Q3 2017$2,729,000
+3.2%
31,786
+0.3%
0.20%
-1.5%
Q2 2017$2,645,000
-15.1%
31,689
-24.5%
0.20%
-16.5%
Q1 2017$3,116,000
+5.2%
41,965
+3.2%
0.24%
+0.4%
Q4 2016$2,961,000
+22.4%
40,653
+32.6%
0.24%
+13.5%
Q3 2016$2,420,000
+7.4%
30,653
+12.2%
0.21%
+5.1%
Q2 2016$2,254,000
+13.3%
27,324
-0.5%
0.20%
+6.5%
Q1 2016$1,990,000
-18.8%
27,475
-3.6%
0.19%
-17.7%
Q4 2015$2,451,000
+11.0%
28,487
+18.6%
0.23%
-9.2%
Q3 2015$2,209,000
-5.2%
24,027
+1.4%
0.25%
+0.8%
Q2 2015$2,330,000
-8.3%
23,691
-8.1%
0.25%
-9.2%
Q1 2015$2,542,000
+9.1%
25,771
+2.5%
0.27%
+8.8%
Q4 2014$2,330,000
+0.1%
25,138
+1.7%
0.25%
-6.0%
Q3 2014$2,327,000
+10.3%
24,725
+6.2%
0.27%
+9.9%
Q2 2014$2,109,000
+8.2%
23,292
+1.7%
0.24%
+0.8%
Q1 2014$1,949,000
+12.5%
22,913
+6.3%
0.24%
+5.7%
Q4 2013$1,733,000
+1.8%
21,560
-2.9%
0.23%
-13.4%
Q3 2013$1,703,000
+10.6%
22,193
+1.9%
0.26%
+4.0%
Q2 2013$1,540,00021,7690.25%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders